Biomarkers & Immuno Series US08 - 09 October 2019 | San Diego, USA

Join over 250 leaders, experts and scientists to discuss key opportunities and challenges in two distinct programmes covering Biomarker-based research and Immuno-Oncology based therapies

Featuring over 80 presentations, the series brings together leading pharma, biotech and academic organisations designing innovative strategies and technologies for more effective biomarker discovery and cancer immunotherapy development.

Key Speakers

The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.

The following are confirmed speakers for the 2019 series.

Kathy Call, Sanofi

Katherine Call

Sanofi

Mike Damore, Halozyme

Michael Damore

Halozyme

Steve Hoffmann, FNIH

Steve Hoffmann

FNIH

catherine sabatos peyton

Catherine Sabatos-Petyon

Novartis

Ruth Seelige

Ruth Seelige

Pfizer

Zhongu Lai

Zhongwu Lai

AstraZeneca

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of on-site experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Event App

Helping you get more from the event with networking features, searchable presentations & attendees, and much more

Sponsorship

A range of customisable opportunities for lead generation, brand building and global business deals. Whether you’re looking to build business, product launch or increase visibility, we provide a variety of highly effective options to suit budget and requirement.